Global Ibuprofen API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Ibuprofen API market size was valued at US$ 771 million in 2024 and is forecast to a readjusted size of USD 1098 million by 2031 with a CAGR of 5.2% during review period.
Ibuprofen (API), also known as ibuprofen, is a non-steroidal anti-inflammatory drug for antipyretics and analgesia. It has good anti-inflammatory, analgesic and antipyretic effects. Compared with general anti-inflammatory and analgesic drugs, it has strong effects and few side effects. It has no obvious side effects on the liver, kidneys and hematopoietic system, especially the gastrointestinal tract. At present, ibuprofen has been included in the pharmacopoeias of many countries such as China, the United States, the United Kingdom, Japan, and the European Pharmacopoeia. It has been widely used around the world and has become one of the world's best-selling over-the-counter drugs.
The Ibuprofen API (Active Pharmaceutical Ingredient) market is primarily driven by the increasing global demand for pain relief and anti-inflammatory medications. Ibuprofen is one of the most commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) for treating conditions such as arthritis, fever, headaches, menstrual pain, and other types of mild to moderate pain. The rising prevalence of chronic conditions, such as osteoarthritis and other inflammatory diseases, is driving the demand for Ibuprofen APIs. Additionally, the growing aging population and increasing awareness about over-the-counter (OTC) pain relief medications have contributed to the market's expansion. Manufacturers are also benefiting from the widespread availability of generic Ibuprofen formulations, which have made the drug more accessible and affordable.
However, the market faces challenges related to regulatory scrutiny and competition in the generic drug market. The production of Ibuprofen APIs requires strict compliance with regulatory standards, and companies must invest in quality control to ensure the safety and efficacy of the product. Furthermore, the generic nature of Ibuprofen leads to intense price competition among manufacturers, squeezing profit margins and making it difficult for companies to maintain market share. Another challenge is the rising concern about the side effects of prolonged Ibuprofen use, such as gastrointestinal issues and cardiovascular risks, which may impact consumer confidence and demand in the long term.
Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.
This report is a detailed and comprehensive analysis for global Ibuprofen API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ibuprofen API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Ibuprofen API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Ibuprofen API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Ibuprofen API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ibuprofen API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ibuprofen API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IOLCP, SOLARA, Shandong Xinhua Pharmaceutical, Biocause, BASF, SI Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ibuprofen API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
USP
EP
Market segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Major players covered
IOLCP
SOLARA
Shandong Xinhua Pharmaceutical
Biocause
BASF
SI Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ibuprofen API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ibuprofen API, with price, sales quantity, revenue, and global market share of Ibuprofen API from 2020 to 2025.
Chapter 3, the Ibuprofen API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ibuprofen API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ibuprofen API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ibuprofen API.
Chapter 14 and 15, to describe Ibuprofen API sales channel, distributors, customers, research findings and conclusion.
Ibuprofen (API), also known as ibuprofen, is a non-steroidal anti-inflammatory drug for antipyretics and analgesia. It has good anti-inflammatory, analgesic and antipyretic effects. Compared with general anti-inflammatory and analgesic drugs, it has strong effects and few side effects. It has no obvious side effects on the liver, kidneys and hematopoietic system, especially the gastrointestinal tract. At present, ibuprofen has been included in the pharmacopoeias of many countries such as China, the United States, the United Kingdom, Japan, and the European Pharmacopoeia. It has been widely used around the world and has become one of the world's best-selling over-the-counter drugs.
The Ibuprofen API (Active Pharmaceutical Ingredient) market is primarily driven by the increasing global demand for pain relief and anti-inflammatory medications. Ibuprofen is one of the most commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) for treating conditions such as arthritis, fever, headaches, menstrual pain, and other types of mild to moderate pain. The rising prevalence of chronic conditions, such as osteoarthritis and other inflammatory diseases, is driving the demand for Ibuprofen APIs. Additionally, the growing aging population and increasing awareness about over-the-counter (OTC) pain relief medications have contributed to the market's expansion. Manufacturers are also benefiting from the widespread availability of generic Ibuprofen formulations, which have made the drug more accessible and affordable.
However, the market faces challenges related to regulatory scrutiny and competition in the generic drug market. The production of Ibuprofen APIs requires strict compliance with regulatory standards, and companies must invest in quality control to ensure the safety and efficacy of the product. Furthermore, the generic nature of Ibuprofen leads to intense price competition among manufacturers, squeezing profit margins and making it difficult for companies to maintain market share. Another challenge is the rising concern about the side effects of prolonged Ibuprofen use, such as gastrointestinal issues and cardiovascular risks, which may impact consumer confidence and demand in the long term.
Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.
This report is a detailed and comprehensive analysis for global Ibuprofen API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ibuprofen API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Ibuprofen API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Ibuprofen API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Ibuprofen API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ibuprofen API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ibuprofen API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IOLCP, SOLARA, Shandong Xinhua Pharmaceutical, Biocause, BASF, SI Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ibuprofen API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
USP
EP
Market segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Major players covered
IOLCP
SOLARA
Shandong Xinhua Pharmaceutical
Biocause
BASF
SI Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ibuprofen API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ibuprofen API, with price, sales quantity, revenue, and global market share of Ibuprofen API from 2020 to 2025.
Chapter 3, the Ibuprofen API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ibuprofen API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ibuprofen API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ibuprofen API.
Chapter 14 and 15, to describe Ibuprofen API sales channel, distributors, customers, research findings and conclusion.
Table of Contents
94 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Ibuprofen API by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
